PROVEER LTD

Executive Summary

Proveer Ltd is a newly established company with a solid start showing positive net assets and timely regulatory compliance. However, its limited operating history and low cash reserves warrant further scrutiny of debtor quality and cash flow sustainability. Concentrated ownership simplifies governance but also introduces typical start-up risks requiring ongoing monitoring.

PROVEER LTD - Analysis Report

Company Number: 15774340

Analysis Date: 2025-07-29 14:33 UTC

1. Risk Rating: LOW
   Proveer Ltd is a newly incorporated private limited company with a modest financial position consistent with its start-up stage. The company shows positive net current assets and no overdue filings, indicating initial compliance and liquidity.

2. Key Concerns:

• Limited Operating History: Incorporated in June 2024, financial data reflects only the first operating period, limiting trend analysis and long-term viability assessment.
• Minimal Cash Reserves: Cash at bank is only £9, which may indicate tight daily liquidity despite positive net current assets mainly driven by debtors.
• Concentrated Control: Single director and 75-100% shareholding by one individual may pose governance and succession risks.

3. Positive Indicators:

• Positive Working Capital: Net current assets of £1,013 show the company currently can meet short-term liabilities (£2,583) with current assets (£3,596).
• No Overdue Filings: Accounts and confirmation statement are filed on time, suggesting good regulatory compliance.
• Clear Ownership and Management: The director is the sole controlling party, simplifying decision-making and accountability.

4. Due Diligence Notes:

• Verify the collectability and quality of trade debtors (£3,587) to ensure working capital reliability.
• Review business plan and cash flow forecasts to confirm operational sustainability beyond start-up phase.
• Monitor any related party transactions given single-person control to assess potential conflicts of interest.
• Confirm intangible asset (goodwill £100) origin and valuation rationale to assess any impairment risk.